We’ve collated our top-performing blogs from the year so far for you to catch up with; because if hundreds of other people read them, they must be worth a few minutes of your time, right?
With examples such as aspirin and penicillin, small molecule drug development has changed the world time and again, producing medications that have saved countless lives. These days, with demand for biologics to treat unmet diseases growing rapidly, is small molecule development in decline? Read more in our article.
To mark Rare Disease Day, our Senior Web Developer, Andy, shared the story of his diagnosis with Fabry disease in August of last year. Andy spoke about how he has benefited from advancements in treatment for this rare disease and his first-hand experience going from symptom to diagnosis.
Scientific content writer, Maria O’Hanlon, recently wrote an article discussing the pharma companies succeeding when it comes to developing clear, actionable ESG initiatives and how what life science companies can do to up their game.
Our new format was a hit and saw March’s review score in the top 5 articles of this year so far! Joao Incio, Bio Sector Lead, headed up this month and covered the SVB crash, advancements in Sickle Cell treatment, and more.
Gillian Dannenberg, Senior Research & Strategy Marketing Manager, explores the importance of brand storytelling and how we can adapt key marketing principles to the life sciences space.
As part of Time to Talk Day in the UK, the ramarketing team shared some key ways we, as an organization, help our teams have a positive workplace environment. The perfect article to provide some inspiration if you’re looking into what more you can do within your companies.
20th June, 2023
If you didn’t already know, ramarketing is the proud sponsor of the leading life...Read more
20th June, 2023
The go-to whitepaper for biotechs involved in ranking and selecting vendors. Co-authored by our...Read more